Celldex Therapeutics buy Cantor Fitzgerald

Summary

This prediction is currently active. The prediction for Celldex Therapeutics disappoints with a performance of -12.37%. This prediction currently runs until 22.03.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Celldex Therapeutics	-6.077%	-6.077%
iShares Core DAX®	2.594%	-1.158%
iShares Nasdaq 100	3.553%	-1.727%
iShares Nikkei 225®	0.687%	-8.354%
iShares S&P 500	2.209%	-0.942%